---
title: "Protagonist Therapeutics President, CEO Sold Shares Worth Over $7.5M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286168816.md"
description: "Dinesh V. Patel, President and CEO of Protagonist Therapeutics, sold shares worth $7.5 million at an average price of $100.12 per share. Following the sale, he retains ownership of 523,478 shares. The sale involved multiple transactions with prices ranging from $98.83 to $103.50, as reported in SEC Form 4 filings."
datetime: "2026-05-12T23:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286168816.md)
  - [en](https://longbridge.com/en/news/286168816.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286168816.md)
---

# Protagonist Therapeutics President, CEO Sold Shares Worth Over $7.5M

Dinesh V. Patel, a director and President, CEO, reported the direct sale of common stock at a weighted average price of $100.12 per share. The total proceeds from the sale were $7,509,000. Following the transaction, Patel directly owned 523,478 shares of common stock. The price reported represents the weighted average sale price; shares were sold in multiple transactions at prices ranging from $98.83 to $103.50.

Reporter Name

Patel Dinesh V Ph D

Relationship

President and CEO

Type

Sell

Amount

$7,509,000

SEC Filing

Form 4

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [PTGX.US](https://longbridge.com/en/quote/PTGX.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Bicara Therapeutics: 1500mg Ficerafusp Alfa + Pembrolizumab Shows Estimated 31% 3‑Year OS in 1L R/M HPV‑Negative HNSCC](https://longbridge.com/en/news/287274216.md)
- [BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO](https://longbridge.com/en/news/287276384.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)